Literature DB >> 759717

Alterations of peripheral testosterone matabolism after induced hypoprolactinemia in patients with prostatic carcinoma.

G H Jacobi, J E Altwein, R Hohenfellner.   

Abstract

In 12 patients with advanced prostatic carcinoma the effect of bromocriptine-induced hypoprolactinemia on the peripheral androgen metabolism was investigated after 3H-testosterone injection under conditions that each individual served as his own control. After a 5-day significant prolactin suppression, the elimination of 3H-label 1 h after testosterone injection was about 45% and equal to pre-bromocriptine values. The recovery of dihydrotestosterone separated by silica gel T.L.C., however, was significantly augmented, resulting in a marked decrease of the testosterone/dihydrotestosterone ratio from 12.2 to 6.3. This induced 5alpha-reductase activity after prolactin suppression is in accordance with our earlier findings on prostatic carcinoma tissue, matches well with observations of Magrini et al. on induced hyperprolactinemia and may be a new approach to the understanding of androgen dependent disorders.

Entities:  

Keywords:  Alkaloids; Androgens; Biology; Clinical Research; Endocrine System; Ergot Alkaloids--administraction and dosage; Genitalia; Genitalia, Male; Hormones; Human Volunteers; Ingredients And Chemicals; Men; Metabolic Effects; Organic Chemicals; Physiology; Pituitary Hormones; Prolactin--analysis; Prostate; Research Methodology; Stanolone--analysis; Steroid Metabolic Effects; Testosterone--analysis; Urogenital System

Mesh:

Substances:

Year:  1979        PMID: 759717     DOI: 10.1007/bf01476982

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  5 in total

Review 1.  [Bromocriptine, a new therapeutic principle in prostatic adenoma and carcinoma. Basis, possibilities, limits].

Authors:  G H Jacobi; J E Altwein
Journal:  Dtsch Med Wochenschr       Date:  1978-05-12       Impact factor: 0.628

2.  Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.

Authors:  R Horton; J F Tait
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

3.  Study on the relationship between plasma prolactin levels and androgen metabolism in man.

Authors:  B Magrini; J R Ebiner; P Burckhardt; J P Felber
Journal:  J Clin Endocrinol Metab       Date:  1976-10       Impact factor: 5.958

4.  [Bromocriptine and prostatic carcinoma: testosterone metabolism in relation to tumor grading (author's transl)].

Authors:  G H Jacobi; K H Kurth; J E Altwein
Journal:  Urologe A       Date:  1979-03       Impact factor: 0.639

5.  Bromocriptine and prostatic carcinoma: plasma kinetics, production and tissue uptake of 3H-testosterone in vivo.

Authors:  G H Jacobi; K Sinterhauf; K H Kurth; J E Altwein
Journal:  J Urol       Date:  1978-02       Impact factor: 7.450

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.